Concepedia

Cecilia Trinks

CT

Statistics

Publications

7

Citations

146

H-Index

7

Active since

2009

Affiliations

Linköping University(Current)

Linköping University Hospital

Cecilia Trinks is an author at Linköping University specializing in tyrosine kinase inhibitors, oncology, and receptor tyrosine kinase signaling.

Publications per year

2009–2020

7

Publications

7

ErbB receptor tyrosine kinases contribute to proliferation of malignant melanoma cells: inhibition by gefitinib (ZD1839)

Emelie A. Djerf, Cecilia Trinks, Avni Abdiu et al. · Melanoma Research · 2009 · 44 citations

, , +17

Inhibitory effect of opiates on LPS mediated release of TNF and IL-8

Salumeh Bastami, Cecilia Norling, Cecilia Trinks et al. · Acta Oncologica · 2012 · 31 citations · Full text

, , +17

The pan-ErbB receptor tyrosine kinase inhibitor canertinib promotes apoptosis of malignant melanoma in vitro and displays anti-tumor activity in vivo

Emelie Severinsson, Cecilia Trinks, Henrik Gréen et al. · Biochemical and Biophysical Research Communications · 2011 · 23 citations

, , +14

The pan-ErbB receptor tyrosine kinase inhibitor canertinib induces ErbB-independent apoptosis in human leukemia (HL-60 and U-937) cells

Cecilia Trinks, Emelie A. Djerf, Anna‐Lotta Hallbeck et al. · Biochemical and Biophysical Research Communications · 2010 · 13 citations

, , +14

Homozygous Missense <i>MYBPC3</i> Pro873His Mutation Associated with Increased Risk for Heart Failure Development in Hypertrophic Cardiomyopathy

Antheia Kissopoulou, Cecilia Trinks, Anna Gréen et al. · ESC Heart Failure · 2018 · 13 citations · Full text

, , +16

1–5 of 7